MedPath

Observation of the effect of Ninjinyoeito on post-treatment malaise in gynecological cancer

Not Applicable
Recruiting
Conditions
Malaise
Registration Number
JPRN-UMIN000045874
Lead Sponsor
Keio University School of Medicine Center for Kampo Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patients who are regularly using other Kampo medicine. 2) The patients with stage IV malignancy 3) The patients with PS(Performance Status) of 3 or 4 4) The patients considered to have a prognosis of less than six months 5) The patients with the experience an allergy after taking any Kampo medicine 6) The patients with a remarkable digestive organ symptom 7) The patients diagnosed with major depressive disorder and undergoing prescription adjustment 8) The patients with aldosteronism, myopathy, hypokalemia, or suspected 9) The patients with hepatic dysfunction (AST>80 IU/L or ALT>80 IU/L) 10) The patients who were judged not to be included by researchers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath